Funded Tech Companies
Protagonist Therapeutics
Operating out of Newark, Protagonist Therapeutics has funding from Canaan Partners, Pharmstandard and Lilly Ventures.
Company Overview
Company Name
Protagonist Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
7707 Gateway Blvd. 140
Newark, CA 94560
USA
Newark, CA 94560
USA
Phone
Website
Email Address
Company Background Information
Overview
Protagonist Therapeutics (NASDAQ: PTGX) is a biotechnology company pursuing the discovery and development of disulfide-rich peptides (DRPs) as well differentiated alternatives to biologics.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/11/2016
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dinesh Patel
Chief Financial Officer
Donald Kalkofen
Chief Medical Officer
Samuel Saks
Chief Scientific Officer
David Liu
VP - Bus. Development
Suneel Gupta
VP - Bus. Development
Tracy Woody
Company Investors
- Canaan Partners (Julie Papanek)
- Pharmstandard
- Lilly Ventures (Armen Shanafelt)
- Johnson & Johnson Development Corporation (Asish Xavier)
- Adage Capital Management
- Starfish Ventures
- Foresite Capital
- RA Capital
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs